Welcome to Grünenthal. This site uses cookies. Read our policy.

Accept Cookies

Innovation &

Finding solutions that improve patients’ lives


We aim to deliver major therapeutic advances by treating patients with a high burden of disease, offering clear benefits for patients and sound health economics for society. Our exciting R&D pipeline includes several new drug candidates and technologies to improve patients’ lives.

At Grünenthal, there is close collaboration between all stakeholders involved in research, and each is equally important. Our networked approach to R&D means that we can interlink and supplement our own expertise with external knowledge, leading to improved outcomes.

Fueling our pipeline with innovation

Latest Updates

Convergences in PP

Convergences in Pelvi-Perineal Pain is a society that aims to promote knowledge about chronic perineal pain. Over the 2-day programme of this society’s 2018 Congress in Brussels, there were many insightful talks by some of the top researchers and clinicians in this field, an overview of these are discussed in this article.

... Discover more

Chronic overlapping pain conditions

In this article by Christin Veasley, Co-Founder & Director of Chronic Pain Research Alliance, the emergence, symptoms, mechanisms and unmet needs of chronic overlapping pain conditions is discussed. Christin hopes to increase the awareness of the issues around chronic pain conditions in America.

... Discover more

Re-defining pain through patient-inspired R&D

... Discover more

Exploring the genome for novel pain targets

There exists significant unmet need for treatments that are targeted to the many underlying mechanisms that cause pain to arise. The genetic study of pain has already revealed some promising targets and it is hoped that research will translate into the development of targeted drugs and the advent of precision medicine in pain. This article summarises current approaches to the genetic study of pain and highlights Grünenthal’s ongoing research in this area.

... Discover more

Intractable and refractory pain

The lack of a clear and consistent definition for chronic neuropathic intractable or refractory pain is one of the main barriers to effective management of these conditions. In this article we have looked into the current thinking of what constitutes ‘refractory’ or ‘intractable’ pain, and the implications that the subtle differences between these words have on the management of these patients.

... Discover more


Share this with:

These are external links and will open in a new window